4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-23-005993
Chief Executive Officer sold 11,313 shares at $3.91 ($44,234)
From the SEC's structured data for this filing
Enliven Therapeutics, Inc. Filed Acc 0001209191-23-005993
Chief Executive Officer sold 11,313 shares at $3.91 ($44,234)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…